Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 49.38 | N/A |
| PEG Ratio (TTM) | 9.01 | N/A |
| P/S Ratio (TTM) | 2.47 | N/A |
| P/B Ratio (TTM) | 2.66 | N/A |
| P/FCF Ratio (TTM) | 31.54 | N/A |
| Price to 5YR AVG Earnings Ratio | 37.54 | N/A |
| Price to 5YR AVG FCF Ratio | 27.89 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.61% | N/A |
| ROE (TTM) | 5.52% | N/A |
| Net Profit Margin (TTM) | 4.97% | N/A |
| ROIC 5YR AVG | 9.52% | N/A |
Growth (37%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1,060.47% | -20.14% | -1.36% |
| Revenue | -0.69% | 0.73% | 3.82% |
| Net Income | 1,124.19% | -22.13% | -2.83% |
| Cash Flow | 1,382.75% | -3.39% | 139.65% |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.72 | N/A |
| Quick Ratio (TTM) | 1.30 | N/A |
| D/E Ratio (TTM) | 0.35 | N/A |
| Interest Coverage (TTM) | 3.57 | N/A |
| Piotroski F-Score | 9 | N/A |
| Altman Z-Score | 2.00 | N/A |
| LTL to 5YR AVG FCF | 3.82 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.71% | N/A |